Home
Jubilant Biosys

Jubilant Biosys Market Share Analysis for November 2025

Jubilant Biosys offers expert commercial manufacturing of APIs, KSMs, RSMs, and intermediates, ensuring high-quality, cGMP-compliant production from early to late phases.

Health > Biotechnology and Pharmaceuticals

Domainjubilantbiosys.com

Year Founded1978

Employees1001 - 5000

Annual Revenue$50M - $75M

Jubilant Biosys

Jubilant Biosys (including company regionals)

jubilantbiosys.com

See more website traffic and engagement information

Jubilant Biosys Revenue up to November 2025 is 50M - 75M

revenue generated by Jubilant Biosys top domains

Jubilant Biosys top domains revenue over 3 years

Revenue for Jubilant Biosys top domains

jubilantbiosys.com50M - 75M

See more with Sales Intelligence

Total visits to Jubilant Biosys's top domains

Understand Jubilant Biosys market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

jubilantbiosys.com13.6K

See more with Sales Intelligence

Avg. visit duration in Jubilant Biosys's top domains

Analyze Jubilant Biosys engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

jubilantbiosys.com00:00:28

See more with Sales Intelligence

Avg. pageviews on Jubilant Biosys's top domains

See how Jubilant Biosys keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

jubilantbiosys.com1.38

See more with Sales Intelligence

Jubilant Biosys top competitors by domain

Top similar sites in November 2025, ranked by their affinity

biovencer.comCompany NameBiovencer Healthcare PrivateEmployees201 - 500HQIndia, NoidaAnnual revenue$2M - $5MTotal visits22.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Jubilant Biosys

These are the website technologies, by industry, used by Jubilant Biosys top domains

Advertising (6)

Google Adsense

Widget (6)

Twemoji

eCommerce (3)

Swap

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Jubilant Biosys

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJubilant Biosys Limited invests into assets: 80 per cent equity capital in the amount of $4.85M in France.With this offer, Jubilant Biosys will acquire 80 per cent equity capital (4.4 million euros over 2 years) in a new company to be incorporated in France.

NewsJubilant Biosys Limited expands offices in India.Pharma company Jubilant Biosys plans to expand India footprint, to foray into new therapeutic areas, says CEO Giuliano Perfetti.

NewsJubilant Biosys Limited expands facilities to India.“I’m delighted that Jubilant Group, a global leader in pharma, will soon set up a state-of-the-art facility in Genome Valley, Hyderabad.